Baker Avenue Asset Management’s Globus Medical GMED Stock Holding History

Baker Avenue Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$466K	Buy	5,904 +3,157	+115%	+$268K	0.01%	531
2026 Q1	$237K	Buy	+2,747	New	+$247K	0.01%	680
2023 Q4	–	Sell	-219	Closed	-$10.9K	–	806
2023 Q3	$10.9K	Buy	219 +211	+2,638%	+$11.8K	﹤0.01%	753
2023 Q2	$476	Buy	+8	New	+$456	﹤0.01%	1429
2023 Q1	–	Sell	-18	Closed	-$1.34K	–	1678
2022 Q4	$1.34K	Buy	+18	New	+$1.23K	﹤0.01%	1021

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Baker Avenue Asset Management's GMED Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Globus Medical (GMED) stake by 115% in Q2 2026, buying an estimated $268K and bringing the position to 5,904 shares worth $466K. The position accounts for 0.01% of the portfolio, ranked #531.

Baker Avenue Asset Management first reported a position in GMED in Q4 2022 and has held it in 5 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Baker Avenue Asset Management held 5,904 shares of Globus Medical worth $466K as of Q2 2026.
Baker Avenue Asset Management bought 3,157 Globus Medical shares in Q2 2026, an estimated $268K.
Globus Medical made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #531 holding.
Baker Avenue Asset Management first reported a position in Globus Medical in Q4 2022 and has held it in 5 quarters since.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.